Summary
Hyperechogenicity of the substantia nigra (SN) has been proposed to be a typical finding in Parkinson’s disease (PD) and a marker of vulnerability to nigrostriatal dysfunction in healthy subjects. This large cross-sectional study including 1120 subjects older than 50 years without any signs of PD was performed to evaluate the association of SN hyperechogenicity and other proposed epidemiological risk factors for PD. Among all variables assessed only family history of PD and male gender proved to be significantly associated with SN hyperechogenicity, indicating a genetic predisposition for the ultrasound marker.
Similar content being viewed by others
References
MF Allam AS Del Castillo RF Navajas (2005) ArticleTitleParkinson’s disease risk factors: genetic, environmental, or both? Neurol Res 27 206–208 10.1179/016164105X22057 Occurrence Handle10.1179/016164105X22057 Occurrence Handle1:CAS:528:DC%2BD2MXjt1ajsLw%3D Occurrence Handle15829184
M Baldereschi A Di Carlo P Vanni A Ghetti P Carbonin L Amaducci et al. (2003) ArticleTitleLifestyle-related risk factors for Parkinson’s disease: a population-based study Acta Neurol Scand 108 239–244 10.1034/j.1600-0404.2003.00128.x Occurrence Handle10.1034/j.1600-0404.2003.00128.x Occurrence Handle1:STN:280:DC%2BD3svls1CntA%3D%3D Occurrence Handle12956856
R Bandopadhyay AE Kingsbury MR Cookson AR Reid IM Evans AD Hope et al. (2004) ArticleTitleThe expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson’s disease Brain 127 420–430 10.1093/brain/awh054 Occurrence Handle10.1093/brain/awh054 Occurrence Handle14662519
G Becker A Muller S Braune T Buttner R Benecke W Greulich et al. (2002) ArticleTitleEarly diagnosis of Parkinson’s disease J Neurol 249 IssueIDSuppl 3 III/40–III/48
S Behnke KL Double S Duma GA Broe V Guenther G Becker GM Halliday (2007) ArticleTitleSubstantia nigra echomorphology in the healthy very old: Correlation with motor slowing Neuroimage 34 1054–1059 10.1016/j.neuroimage.2006.10.010 Occurrence Handle10.1016/j.neuroimage.2006.10.010 Occurrence Handle1:STN:280:DC%2BD2s%2Fis1ajtQ%3D%3D Occurrence Handle17141529
J Benito-Leon F Bermejo-Pareja JM Morales-Gonzalez J Porta-Etessam R Trincado S Vega et al. (2004) ArticleTitleIncidence of Parkinson disease and parkinsonism in three elderly populations of central Spain Neurology 62 734–741 Occurrence Handle1:STN:280:DC%2BD2c7hslylsQ%3D%3D Occurrence Handle15007123
D Berg (2006a) ArticleTitleMarker for a preclinical diagnosis of Parkinson’s disease as a basis for neuroprotection J Neural Transm 71 IssueIDSuppl 1–10
D Berg (2006b) ArticleTitleTranscranial sonography in the early and differential diagnosis of Parkinson’s disease J Neural Transm 70 IssueIDSuppl 249–254 Occurrence Handle10.1007/978-3-211-45295-0_38
D Berg G Becker (2002) ArticleTitlePerspectives of B-mode transcranial ultrasound Neuroimage 15 463–473 10.1006/nimg.2001.1014 Occurrence Handle10.1006/nimg.2001.1014 Occurrence Handle11848690
D Berg G Becker B Zeiler O Tucha E Hofmann M Preier et al. (1999) ArticleTitleVulnerability of the nigrostriatal system as detected by transcranial ultrasound Neurology 53 1026–1031 Occurrence Handle1:STN:280:DyaK1MvisVGrsw%3D%3D Occurrence Handle10496262
D Berg B Merz K Reiners M Naumann G Becker (2005) ArticleTitleFive-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson’s disease Mov Disord 20 383–385 10.1002/mds.20311 Occurrence Handle10.1002/mds.20311 Occurrence Handle15486999
D Berg W Roggendorf U Schroder R Klein T Tatschner P Benz et al. (2002) ArticleTitleEchogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury Arch Neurol 59 999–1005 10.1001/archneur.59.6.999 Occurrence Handle10.1001/archneur.59.6.999 Occurrence Handle12056937
D Berg C Siefker G Becker (2001) ArticleTitleEchogenicity of the substantia nigra in Parkinson’s disease and its relation to clinical findings J Neurol 248 684–689 10.1007/s004150170114 Occurrence Handle10.1007/s004150170114 Occurrence Handle1:STN:280:DC%2BD3MritFWltQ%3D%3D Occurrence Handle11569897
JH Bower DM Maraganore SK McDonnell WA Rocca (1999) ArticleTitleIncidence and distribution of parkinsonism in Olmstead County, Minnesota, 1976–1990 Neurology 52 1214–1220 Occurrence Handle1:STN:280:DyaK1M3ivFGmuw%3D%3D Occurrence Handle10214746
LM de Lau MM Breteler (2006) ArticleTitleEpidemiology of Parkinson’s disease Lancet Neurol 5 525–535 10.1016/S1474-4422(06)70471-9 Occurrence Handle10.1016/S1474-4422(06)70471-9 Occurrence Handle16713924
MC de Rijk C Tzourio MM Breteler JF Dartigues L Amaducci S Lopez-Pousa et al. (1997) ArticleTitlePrevalence of parkinsonism and Parkinson’s disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson’s disease J Neurol Neurosurg Psychiatry 62 10–15 Occurrence Handle10.1136/jnnp.62.1.10 Occurrence Handle1:STN:280:DyaK2s7mtlGrtA%3D%3D Occurrence Handle9010393
PA Fall O Axelson M Frederiksson G Hansson B Lindvall JE Olsson et al. (1996) ArticleTitleAge-standardized incidence and prevalence of Parkinson’s disease in a Swedish community J Clin Epidemiol 49 637–647 10.1016/0895-4356(96)00003-0 Occurrence Handle10.1016/0895-4356(96)00003-0 Occurrence Handle1:STN:280:DyaK283kvFGhsA%3D%3D Occurrence Handle8656224
JM Fearnley AJ Lees (1991) ArticleTitleAgeing and Parkinson’s disease: substantia nigra regional selectivity Brain 114 2283–2301 10.1093/brain/114.5.2283 Occurrence Handle10.1093/brain/114.5.2283 Occurrence Handle1933245
LI Golbe (1990) ArticleTitleThe genetics of Parkinson’s disease: a reconsideration Neurology 40 IssueIDSuppl 3 7–14 Occurrence Handle2215974
JM Gorell EL Peterson BA Rybicki CC Johnson (2004) ArticleTitleMultiple risk factors for Parkinson’s disease J Neurol Sci 217 169–174 10.1016/j.jns.2003.09.014 Occurrence Handle10.1016/j.jns.2003.09.014 Occurrence Handle14706220
JP Hubble T Cao RE Hassanein JS Neuberger WC Koller (1993) ArticleTitleRisk factors for Parkinson’s disease Neurology 43 1693–1697 Occurrence Handle1:STN:280:DyaK2c%2FitVarug%3D%3D Occurrence Handle8414014
A Iova A Garmashov N Androuchtchenko M Kehrer D Berg G Becker et al. (2004) ArticleTitlePostnatal decrease in substantia nigra echogenicity. Implications for the pathogenesis of Parkinson’s disease J Neurol 251 1451–1454 10.1007/s00415-004-0556-3 Occurrence Handle10.1007/s00415-004-0556-3 Occurrence Handle15645343
WC Koller (1992) ArticleTitleWhen does Parkinson’s disease begin? Neurology 42 IssueIDSuppl 4 27–31 Occurrence Handle1:STN:280:DyaK383mtFyqsg%3D%3D Occurrence Handle1350072
KE Lyons JP Hubble AI Troster R Pahwa WC Koller (1998) ArticleTitleGender differences in Parkinson’s disease Clin Neuropharmacol 21 118–121 Occurrence Handle1:STN:280:DyaK1c3ktVClsw%3D%3D Occurrence Handle9579298
K Marder G Levy ED Louis H Mejia-Santana L Cote H Andrews et al. (2003) ArticleTitleFamilial aggregation of early- and late-onset Parkinson’s disease Ann Neurol 54 507–513 10.1002/ana.10711 Occurrence Handle10.1002/ana.10711 Occurrence Handle14520664
RH Mindham (1970) ArticleTitlePsychiatric symptoms in Parkinsonism J Neurol Neurosurg Psychiatry 33 188–191 10.1136/jnnp.33.2.188 Occurrence Handle10.1136/jnnp.33.2.188 Occurrence Handle1:STN:280:DyaE3c7otFamsA%3D%3D Occurrence Handle5443478
AH Robins (1976) ArticleTitleDepression in patients with Parkinsonism Br J Psychiatry 128 141–145 10.1192/bjp.128.2.141 Occurrence Handle10.1192/bjp.128.2.141 Occurrence Handle1:STN:280:DyaE287js12rtg%3D%3D Occurrence Handle130180
WA Rocca SK McDonnell KJ Strain JH Bower JE Ahlskog A Elbaz et al. (2004) ArticleTitleFamilial aggregation of Parkinson’s disease: The Mayo Clinic family study Ann Neurol 56 495–502 10.1002/ana.20228 Occurrence Handle10.1002/ana.20228 Occurrence Handle15455403
P Ruprecht-Dorfler D Berg O Tucha P Benz M Meier-Meitinger GL Alders et al. (2003) ArticleTitleEchogenicity of the substantia nigra in relatives of patients with sporadic Parkinson’s disease Neuroimage 18 416–422 10.1016/S1053-8119(02)00035-6 Occurrence Handle10.1016/S1053-8119(02)00035-6 Occurrence Handle12595195
J Santamaria E Tolosa A Valles (1986) ArticleTitleParkinson’s disease with depression: a possible subgroup of idiopathic parkinsonism Neurology 36 1130–1133 Occurrence Handle1:STN:280:DyaL283osFCrsA%3D%3D Occurrence Handle3736883
R Saunders-Pullmann (2003) ArticleTitleEstrogens and Parkinson disease: neuroprotective, symptomatic, neither or both? Endocrine 21 81–87 10.1385/ENDO:21:1:81 Occurrence Handle10.1385/ENDO:21:1:81
H Sawada S Shimohama (2003) ArticleTitleEstrogens and Parkinson disease: novel approach for neuroprotection Endocrine 21 77–79 10.1385/ENDO:21:1:77 Occurrence Handle10.1385/ENDO:21:1:77 Occurrence Handle1:CAS:528:DC%2BD3sXkvFSiu7o%3D Occurrence Handle12777706
A Schrag Y Ben-Shlomo NP Quinn (2000) ArticleTitleCross sectional prevalence survey of ideopathic Parkinson’s disease and parkinsonism in London BMJ 321 21–22 10.1136/bmj.321.7252.21 Occurrence Handle10.1136/bmj.321.7252.21 Occurrence Handle1:STN:280:DC%2BD3czosValtA%3D%3D Occurrence Handle10875828
J Spiegel D Hellwig MO Mollers S Behnke W Jost K Fassbender et al. (2006) ArticleTitleTranscranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson’s disease Brain 129 1188–1193 10.1093/brain/awl042 Occurrence Handle10.1093/brain/awl042 Occurrence Handle16513685
SK Van den Eeden CM Tanner L Bernstein RD Fross A Leimpeter DA Bloch et al. (2003) ArticleTitleIncidence of Parkinson’s disease: variation by age, gender and race/ethnicity Am J Epidemiol 157 1015–1023 10.1093/aje/kwg068 Occurrence Handle10.1093/aje/kwg068 Occurrence Handle12777365
U Walter C Klein R Hilker R Benecke PP Pramstaller D Dressler (2004) ArticleTitleBrain parenchyma sonography detects preclinical parkinsonism Mov Disord 19 1445–1449 10.1002/mds.20232 Occurrence Handle10.1002/mds.20232 Occurrence Handle15390070
U Walter M Wittstock R Benecke D Dressler (2002) ArticleTitleSubstantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson’s disease J Neural Transm 109 191–196 10.1007/s007020200015 Occurrence Handle10.1007/s007020200015 Occurrence Handle1:STN:280:DC%2BD38zjt1Gqsg%3D%3D Occurrence Handle12075859
L Zecca D Berg T Arzberger P Ruprecht WD Rausch M Musicco et al. (2005) ArticleTitleIn vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage Mov Disord 20 1278–1285 10.1002/mds.20550 Occurrence Handle10.1002/mds.20550 Occurrence Handle15986424
L Zecca MB Youdim P Riederer JR Connor RR Crichton (2004) ArticleTitleIron, brain ageing and neurodegenerative disorders Nat Rev Neurosci 5 863–873 10.1038/nrn1537 Occurrence Handle10.1038/nrn1537 Occurrence Handle1:CAS:528:DC%2BD2cXos1Ojtrc%3D Occurrence Handle15496864
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schweitzer, K., Behnke, S., Liepelt, I. et al. Cross-sectional study discloses a positive family history for Parkinson’s disease and male gender as epidemiological risk factors for substantia nigra hyperechogenicity. J Neural Transm 114, 1167–1171 (2007). https://doi.org/10.1007/s00702-007-0725-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-007-0725-5